DECREASE IN HUMAN STRIATAL DOPAMINE-D2 RECEPTOR DENSITY WITH AGE - A PET STUDY WITH [C-11] RACLOPRIDE

被引:191
作者
RINNE, JO
HIETALA, J
RUOTSALAINEN, U
SAKO, E
LAIHINEN, A
NAGREN, K
LEHIKOINEN, P
OIKONEN, V
SYVALAHTI, E
机构
[1] UNIV TURKU, DEPT PHARMACOL, SF-20520 TURKU 52, FINLAND
[2] TURKU MED CYCLOTRON PET CTR, RADIOCHEM LAB, TURKU, FINLAND
关键词
AGING; D2; RECEPTORS; DOPAMINE; POSITRON EMISSION TOMOGRAPHY; RACLOPRIDE;
D O I
10.1038/jcbfm.1993.39
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of age on human striatal dopamine D2 receptors was investigated with positron emission tomography (PET) using [C-11]raclopride as a radioligand. Twenty-one healthy volunteers aged from 20 to 81 years were studied. An equilibrium method was applied and two separate PET scans with different specific activities of [C-11]raclopride were performed. The maximal number of receptors (B(max)) and their dissociation constant (K(d)) were calculated using Scatchard analysis. There was an age-dependent decline in the B(max) (r = -0.49; p = 0.02) of striatal D2 receptors while the K(d) remained unchanged. The results show that there is an age-related loss of striatal D2 receptors, which, together with other changes in the brain nigrostriatal dopaminergic system, may contribute to extrapyramidal symptoms associated with aging.
引用
收藏
页码:310 / 314
页数:5
相关论文
共 32 条
[1]  
ANTONIONI AA, 1992, MED APPL CYCLOTRONS, V6, P83
[2]   LOSS OF STRIATAL [BR-76] BROMOSPIPERONE BINDING-SITES DEMONSTRATED BY POSITRON TOMOGRAPHY IN PROGRESSIVE SUPRANUCLEAR PALSY [J].
BARON, JC ;
MAZIERE, B ;
LOCH, C ;
CAMBON, H ;
SGOUROPOULOS, P ;
BONNET, AM ;
AGID, Y .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1986, 6 (02) :131-136
[3]  
CARLSSON A, 1980, PARKINSONS DISEASE C, P121
[4]   AGE-RELATED-CHANGES IN THE HUMAN NIGROSTRIATAL DOPAMINERGIC SYSTEM [J].
DEKEYSER, J ;
EBINGER, G ;
VAUQUELIN, G .
ANNALS OF NEUROLOGY, 1990, 27 (02) :157-161
[5]   STEREOSELECTIVE BINDING OF 11C-RACLOPRIDE IN LIVING HUMAN-BRAIN - A SEARCH FOR EXTRASTRIATAL CENTRAL D2-DOPAMINE RECEPTORS BY PET [J].
FARDE, L ;
PAULI, S ;
HALL, H ;
ERIKSSON, L ;
HALLDIN, C ;
HOGBERG, T ;
NILSSON, L ;
SJOGREN, I ;
STONEELANDER, S .
PSYCHOPHARMACOLOGY, 1988, 94 (04) :471-478
[6]  
FARDE L, 1990, ARCH GEN PSYCHIAT, V47, P213
[7]   QUANTITATIVE-ANALYSIS OF D2 DOPAMINE RECEPTOR-BINDING IN THE LIVING HUMAN-BRAIN BY PET [J].
FARDE, L ;
HALL, H ;
EHRIN, E ;
SEDVALL, G .
SCIENCE, 1986, 231 (4735) :258-261
[8]   KINETIC-ANALYSIS OF CENTRAL [C-11] RACLOPRIDE BINDING TO D2-DOPAMINE RECEPTORS STUDIED BY PET - A COMPARISON TO THE EQUILIBRIUM-ANALYSIS [J].
FARDE, L ;
ERIKSSON, L ;
BLOMQUIST, G ;
HALLDIN, C .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1989, 9 (05) :696-708
[9]   CENTRAL DOPAMINERGIC PATHWAYS IN HEMIPARKINSONISM EXAMINED BY POSITRON EMISSION TOMOGRAPHY [J].
GARNETT, ES ;
NAHMIAS, C ;
FIRNAU, G .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1984, 11 (01) :174-179
[10]   HUMAN DOPAMINE RECEPTOR SUBTYPES - INVITRO BINDING ANALYSIS USING H-3 SCH 23390 AND H-3 RACLOPRIDE [J].
HALL, H ;
FARDE, L ;
SEDVALL, G .
JOURNAL OF NEURAL TRANSMISSION, 1988, 73 (01) :7-21